Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma

BACKGROUND: To date, the rapid clearance from ocular surface has been a huge obstacle for using eye drops to treat glaucoma, since it has led to the short preocular residence time and low bioavailability. METHODS: The novel nanoparticles (NPs) were designed for topical ophthalmic controlled drug del...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Juan, Tian, Shuangyan, Tao, Qi, Zhao, Yawen, Gui, Ruyi, Yang, Fan, Zang, Lingquan, Chen, Yanzhong, Ping, Qineng, Hou, Dongzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045908/
https://www.ncbi.nlm.nih.gov/pubmed/30022821
http://dx.doi.org/10.2147/IJN.S162306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045908/
https://www.ncbi.nlm.nih.gov/pubmed/30022821
http://dx.doi.org/10.2147/IJN.S162306

Ejemplares similares